This 1 hour accredited program will help pharmacists review best-practice management of medicines used in the management of PsA and will help you identify patients who may require re-assessment by their prescriber. Recognising when PsA is sub-optimally controlled and identifying patients who require prompt referral to a rheumatologist for escalation of treatment (including newer oral agents) will help control disease and help prevent progressive joint damage.
The Role of the Pharmacist in Optimising Patient Outcomes in Psoriatic Arthritis – Certificate of Completion
AUS
$0
free
Certificate of Completion
1 hr
Rheumatology, Dermatology
1 Credits
Course Description
Course Details
Expiry Date: 2021-11-23
Professions: Pharmacy
Faculty
Debbie Rigby,
BPharm, GradDipClinPharm, AdvDipNutrPharm, AdvPracPharm
AACPA, FPS, FASCP, FACP, FSHP FAICD
Accreditation
This interactive online learning activity is valued at 1 Hour(s) of continuing education.
Learning Objective(s)
Upon completion of this program, participants will be able to:
- Identify patients with psoriatic arthritis (PsA) who may require treatment optimisation and/or intensification due to the negative impact of treatment with DMARDs on their quality of life
- Individualise management of PsA patients by considering how a variety of factors, including safety, adverse effects of treatment and convenience of treatment regimens, may impact treatment targets
- Recognise the role pharmacists can play in encouraging and empowering patients to ask GPs and/or specialists about newer treatment options in PsA
- Counsel and engage their patients with PsA regarding adherence to treatment through exploring patient beliefs, attitudes, goals and preferences